Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
This comparison highlights retirement index funds with the smallest fees, helping you choose cost-efficient options for a brighter retirement.
27,068 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A new $6 billion prize pool is attracting tech giants as they vie for breakthroughs in AI-safe security, cloud resili...
Meta Platforms is gaining momentum in July 2026 as advertisers lean into AI-powered targeting. This piece explains wh...
Oklo stock has faced big swings, but analysts see a potential upside. This guide breaks down what the projection to $...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
Amazon unveils a sweeping $200 billion capex plan focused on AWS and AI infra, prompting investor debate on the compa...
MiMedx (MDXG) 2025 earnings scrutiny goes beyond one quarter. This guide breaks down what to watch in the Q4 call, ho...
Monster Beverage's 2025 earnings outlook centers on international growth, margin improvements, and strategic branding...
Analysts warn that electrifying AI data centers by 2030 could require $1.4 trillion in investment, driven by surging ...
A fiery address from Palantir’s CEO has ignited a broader debate on how AI firms partner with the Pentagon and how po...
Bitcoin dominance shows signs of cooling as Ethereum takes the lead, with the total crypto market cap topping $2.38 t...